您使用提示模式 关闭

FTXH - First Trust Nasdaq Pharmaceuticals ETF (USD) (US33738R8372)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
US33738R8372
FTXH ISIN
交易所交易基金 (ETF)
基金类型
First Trust
提供商
34,53 USD
每股资产净值 | 2026-06-03
2016-09-20
成立日期
4 每年的次数
股息的支付
CEOXMX
CFI
FTXH
代码
Formed
Status
Equity
投资项目
Healthcare
部门
USA
地区分布
Nasdaq US Smart Pharmaceuticals Index
基准
0.6 %
总成本比率
34,53 百万 USD
基金资产总量 | 2026-06-03
34,53 百万 USD
股票类资产 | 2026-06-03
否
UCITS

收益率 在 2026-06-03, NASDAQ

  • YTD
    1,9 %
  • 1M
    -3,36 %
  • 3M
    -4,14 %
  • 6M
    6,24 %
  • 1Y
    35,3 %
  • 3Y
    33,95 %
  • 5Y
    36,59 %
  • 10Y
    -
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (FTXH)

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

FTXH profile

The First Trust Nasdaq Pharmaceuticals ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The First Trust fund’s base currency is USD and the share class was registered 20.09.2016 with unique ISIN - US33738R8372. Main exchange is NASDAQ and ticker symbol is FTXH. The total expense ratio is 0.6%. The First Trust Nasdaq Pharmaceuticals ETF (USD) pays dividends 4 time(s) per year.

结构 FTXH 在 2026-06-03

下载结构至 Excel 文档
证券 值
Eli Lilly and Company 7,73%
AbbVie Inc. 7,05%
Merck & Co., Inc. 6,98%
Johnson & Johnson 6,77%
Bristol-Myers Squibb Company 6,61%
Viatris Inc. 3,93%
Biogen Inc. 3,85%
Pfizer Inc. 3,45%
Amgen Inc. 3,28%
Gilead Sciences, Inc. 3,26%
Vertex Pharmaceuticals Incorporated 3,25%
Cardinal Health, Inc. 3,22%
United Therapeutics Corporation 3,05%
Regeneron Pharmaceuticals, Inc. 2,98%
Jazz Pharmaceuticals Plc 2,64%
Incyte Corporation 2,29%
Zoetis Inc. 2,23%
Illumina, Inc. 2,13%
Exelixis, Inc. 1,81%
Neurocrine Biosciences, Inc. 1,48%
Medpace Holdings, Inc. 1,33%
Charles River Laboratories International, Inc. 1,3%
PTC Therapeutics, Inc. 1,28%
Alkermes Plc 1,22%
Halozyme Therapeutics, Inc. 1,19%
BioMarin Pharmaceutical Inc. 1,18%
Elanco Animal Health Incorporated 0,92%
Spyre Therapeutics, Inc. 0,89%
Twist Bioscience Corporation 0,8%
Travere Therapeutics, Inc. 0,79%
10X Genomics, Inc. (Class A) 0,72%
Catalyst Pharmaceuticals, Inc. 0,7%
Guardant Health, Inc. 0,7%
TG Therapeutics, Inc. 0,69%
Arrowhead Pharmaceuticals, Inc. 0,65%
Arcus Biosciences, Inc. 0,61%
Ligand Pharmaceuticals Inc. (Class B) 0,61%
Amneal Pharmaceuticals, Inc. 0,57%
Krystal Biotech, Inc. 0,57%
Protagonist Therapeutics, Inc. 0,54%
Mirum Pharmaceuticals, Inc. 0,52%
Roivant Sciences Ltd. 0,51%
Ionis Pharmaceuticals, Inc. 0,47%
Moderna, Inc. 0,47%
Alnylam Pharmaceuticals, Inc. 0,46%
ACADIA Pharmaceuticals Inc. 0,45%
Kymera Therapeutics, Inc. 0,42%
Supernus Pharmaceuticals, Inc. 0,42%
Arcutis Biotherapeutics, Inc. 0,41%
Tarsus Pharmaceuticals, Inc. 0,4%
US Dollar 0,21%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权